Associations of cholecystectomy with the risk of colorectal cancer: a Mendelian randomization study

被引:1
作者
Chen Lanlan [1 ]
Fan Zhongqi [1 ]
Sun Xiaodong [1 ]
Qiu Wei [1 ]
Mu Wentao [1 ]
Chai Kaiyuan [1 ]
Cao Yannan [1 ]
Wang Guangyi [1 ]
Lv Guoyue [1 ]
机构
[1] Department of Hepatobiliary and Pancreatic Surgery
[2] General Surgery Center  3. First Hospital of Jilin University  4. Changchun  5. Jilin 13
基金
中国国家自然科学基金;
关键词
Cholelithiasis; Irritable bowel syndrome; Inflammatory bowel disease; Causal inference; Colorectal cancer; Cholecystectomy; Mendelian randomization;
D O I
暂无
中图分类号
R735.34 [];
学科分类号
100214 ;
摘要
Background: Cholecystectomy is a standard surgery for patients suffering from gallbladder diseases, while the causal effects of cholecystectomy on colorectal cancer (CRC) and other complications are still unknown.Methods: We obtained genetic variants associated with cholecystectomy at a genome-wide significant level (P value <5 × 10-8) as instrumental variables (IVs) and performed Mendelian randomization (MR) to identify the complications of cholecystectomy. Furthermore, the cholelithiasis was also treated as the exposure to compare its causal effects to those of cholecystectomy, and multivariable MR analysis was carried out to judge whether the effect of cholecystectomy was independent of cholelithiasis. The study was reported based on Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization guidelines.Results: The selected IVs explained 1.76% variance of cholecystectomy. Our MR analysis suggested that cholecystectomy cannot elevate the risk of CRC (odds ratio [OR] =1.543, 95% confidence interval [CI]: 0.607–3.924). Also, it was not significant in either colon or rectum cancer. Intriguingly, cholecystectomy might decrease the risk of Crohn’s disease (OR = 0.078, 95% CI: 0.016-0.368) and coronary heart disease (OR = 0.352, 95% CI: 0.164–0.756). However, it might increase the risk of irritable bowel syndrome (IBS) (OR = 7.573, 95% CI: 1.096–52.318). Cholelithiasis could increase the risk of CRC in the largest population (OR = 1.041, 95% CI: 1.010–1.073). The multivariable MR analysis suggested that genetic liability to cholelithiasis could increase the risk of CRC in the largest population (OR = 1.061, 95% CI: 1.002–1.125) after adjustment of cholecystectomy.Conclusions: The study indicated that cholecystectomy might not increase the risk of CRC, but such a conclusion needs further proving by clinical equivalence. Additionally, it might increase the risk of IBS, which should be paid attention to in clinical practice.
引用
收藏
相关论文
共 50 条
  • [31] Assessing the causal association between 731 immunophenotypes and the risk of colorectal cancer: a Mendelian randomization study
    Gao, Fei
    Zhang, Qiaoli
    Teng, Fei
    Li, Liling
    Jiang, Honglin
    Li, Wenna
    Hu, Chenxi
    Lu, Zhongwen
    Wan, Yuxiang
    Huang, Jinchang
    BMC CANCER, 2025, 25 (01)
  • [32] Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study
    Papadimitriou, Nikos
    Bull, Caroline J.
    Jenab, Mazda
    Hughes, David J.
    Bell, Joshua A.
    Sanderson, Eleanor
    Timpson, Nicholas J.
    Smith, George Davey
    Albanes, Demetrius
    Campbell, Peter T.
    Kury, Sebastien
    Le Marchand, Loic
    Ulrich, Cornelia M.
    Visvanathan, Kala
    Figueiredo, Jane C.
    Newcomb, Polly A.
    Pai, Rish K.
    Peters, Ulrike
    Tsilidis, Kostas K.
    Boer, Jolanda M. A.
    Vincent, Emma E.
    Mariosa, Daniela
    Gunter, Marc J.
    Richardson, Tom G.
    Murphy, Neil
    BMC MEDICINE, 2023, 21 (01)
  • [33] Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study
    Nikos Papadimitriou
    Caroline J. Bull
    Mazda Jenab
    David J. Hughes
    Joshua A. Bell
    Eleanor Sanderson
    Nicholas J. Timpson
    George Davey Smith
    Demetrius Albanes
    Peter T. Campbell
    Sébastien Küry
    Loic Le Marchand
    Cornelia M. Ulrich
    Kala Visvanathan
    Jane C. Figueiredo
    Polly A. Newcomb
    Rish K. Pai
    Ulrike Peters
    Kostas K. Tsilidis
    Jolanda M. A. Boer
    Emma E. Vincent
    Daniela Mariosa
    Marc J. Gunter
    Tom G. Richardson
    Neil Murphy
    BMC Medicine, 21
  • [34] Association between cholelithiasis, cholecystectomy, and risk of breast and gynecological cancers: Evidence from meta-analysis and Mendelian randomization study
    Peng, Jing
    Li, Lianghua
    Ning, Huai
    Li, Xiaocheng
    ANNALS OF HUMAN GENETICS, 2024, 88 (06) : 423 - 435
  • [35] Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study
    Chen, Min
    Chen, Qian
    Xiao, Xin-Yu
    Feng, Si-Jia
    Wang, Xiao-Ying
    Tang, Tai-Chun
    Zheng, Hui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Dehydroepiandrosterone Sulfate and Colorectal Cancer Risk: A Mendelian Randomization Analysis
    Jayarathna, Dulari K.
    Renteria, Miguel E.
    Kho, Pik Fang
    Batra, Jyotsna
    Gandhi, Neha S.
    TWIN RESEARCH AND HUMAN GENETICS, 2022, 25 (4-5) : 180 - 186
  • [37] Protective role of gout against colorectal cancer: a Mendelian randomization study
    Pan, Xia
    Liu, Yong'an
    Zhang, Xiaoming
    Meng, Yan
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [38] Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
    Wang, Xiaoliang
    Dai, James Y.
    Albanes, Demetrius
    Arndt, Volker
    Berndt, Sonja I.
    Bezieau, Stephane
    Brenner, Hermann
    Buchanan, Daniel D.
    Butterbach, Katja
    Caan, Bette
    Casey, Graham
    Campbell, Peter T.
    Chan, Andrew T.
    Chen, Zhengyi
    Chang-Claude, Jenny
    Cotterchio, Michelle
    Easton, Douglas F.
    Giles, Graham G.
    Giovannucci, Edward
    Grady, William M.
    Hoffmeister, Michael
    Hopper, John L.
    Hsu, Li
    Jenkins, Mark A.
    Joshi, Amit D.
    Lampe, Johanna W.
    Larsson, Susanna C.
    Lejbkowicz, Flavio
    Li, Li
    Lindblom, Annika
    Le Marchand, Loic
    Martin, Vicente
    Milne, Roger L.
    Moreno, Victor
    Newcomb, Polly A.
    Offitt, Kenneth
    Ogino, Shuji
    Pharoah, Paul D. P.
    Pinchev, Mila
    Potter, John D.
    Rennert, Hedy S.
    Rennert, Gad
    Saliba, Walid
    Schafmayer, Clemens
    Schoen, Robert E.
    Schrotz-King, Petra
    Slattery, Martha L.
    Song, Mingyang
    Stegmaier, Christa
    Weinstein, Stephanie J.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 767 - 780
  • [39] Cathepsins and cancer risk: a Mendelian randomization study
    Deng, Tingting
    Lu, Xixue
    Jia, Xuemin
    Du, Jinxin
    Wang, Lijuan
    Cao, Baorui
    Yang, Meina
    Yin, Ying
    Liu, Fanjie
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [40] Diabetes and cancer risk: A Mendelian randomization study
    Goto, Atsushi
    Yamaji, Taiki
    Sawada, Norie
    Momozawa, Yukihide
    Kamatani, Yoichiro
    Kubo, Michiaki
    Shimazu, Taichi
    Inoue, Manami
    Noda, Mitsuhiko
    Tsugane, Shoichiro
    Iwasaki, Motoki
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (03) : 712 - 719